Literature DB >> 21713375

Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease.

Jannette Rodriguez-Pallares1, Juan Andres Parga, Belen Joglar, Maria Jose Guerra, Jose Luis Labandeira-Garcia.   

Abstract

Recent studies have shown that renin-angiotensin system overactivation is involved in the aging process in several tissues as well as in longevity and aging-related degenerative diseases by increasing oxidative damage and inflammation. We have recently shown that angiotensin II enhances dopaminergic degeneration by increasing levels of reactive oxygen species and neuroinflammation, and that there is an aging-related increase in angiotensin II activity in the substantia nigra in rats, which may constitute a major factor in the increased risk of Parkinson's disease with aging. The mechanisms involved in the above mentioned effects and particularly a potential angiotensin-mitochondria interaction have not been clarified. The present study revealed that activation of mitochondrial ATP-sensitive potassium channels [mitoK(ATP)] may play a major role in the angiotensin II-induced effects on aging and neurodegeneration. Inhibition of mitoK(ATP) channels with 5-hydroxydecanoic acid inhibited the increase in dopaminergic cell death induced by angiotensin II, as well as the increase in superoxide/superoxide-derived reactive oxygen species levels and the angiotensin II-induced decrease in the mitochondrial inner membrane potential in cultured dopaminergic neurons. The present study provides data for considering brain renin-angiotensin system and mitoK(ATP) channels as potential targets for protective therapy in aging-associated diseases such as Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713375      PMCID: PMC3682060          DOI: 10.1007/s11357-011-9284-7

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  87 in total

Review 1.  NADPH oxidase: an update.

Authors:  B M Babior
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside.

Authors:  P P Michel; M Ruberg; Y Agid
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

3.  Analysis of mitochondrial morphology and function with novel fixable fluorescent stains.

Authors:  M Poot; Y Z Zhang; J A Krämer; K S Wells; L J Jones; D K Hanzel; A G Lugade; V L Singer; R P Haugland
Journal:  J Histochem Cytochem       Date:  1996-12       Impact factor: 2.479

4.  Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.

Authors:  K D Garlid; P Paucek; V Yarov-Yarovoy; H N Murray; R B Darbenzio; A J D'Alonzo; N J Lodge; M A Smith; G J Grover
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels.

Authors:  H Hu; T Sato; J Seharaseyon; Y Liu; D C Johns; B O'Rourke; E Marbán
Journal:  Mol Pharmacol       Date:  1999-06       Impact factor: 4.436

6.  Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl.

Authors:  J S Wadia; R M Chalmers-Redman; W J Ju; G W Carlile; J L Phillips; A D Fraser; W G Tatton
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

7.  Induction of a permeability transition in rat kidney mitochondria by pentachlorobutadienyl cysteine: a beta-lyase-independent process.

Authors:  P C Brown; P M Sokolove; D J McCann; J L Stevens; T W Jones
Journal:  Arch Biochem Biophys       Date:  1996-07-15       Impact factor: 4.013

8.  Regional distribution of sulfonylurea receptors in the brain of rodent and primate.

Authors:  S Zini; E Tremblay; H Pollard; J Moreau; Y Ben-Ari
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

Review 9.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

10.  Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes.

Authors:  D Métivier; B Dallaporta; N Zamzami; N Larochette; S A Susin; I Marzo; G Kroemer
Journal:  Immunol Lett       Date:  1998-04       Impact factor: 3.685

View more
  17 in total

1.  Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Authors:  Juan Andrés Parga; María García-Garrote; Salvador Martínez; Ángel Raya; José Luis Labandeira-García; Jannette Rodríguez-Pallares
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

2.  Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.

Authors:  Stefano G Daniele; Dawn Béraud; Connor Davenport; Kui Cheng; Hang Yin; Kathleen A Maguire-Zeiss
Journal:  Sci Signal       Date:  2015-05-12       Impact factor: 8.192

3.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

4.  Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.

Authors:  Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Jose L Lanciego; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Age (Dordr)       Date:  2012-09-18

5.  Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.

Authors:  Pablo Garrido-Gil; Belen Joglar; Ana I Rodriguez-Perez; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  J Neuroinflammation       Date:  2012-02-22       Impact factor: 8.322

6.  Da-bu-yin-wan and qian-zheng-san to neuroprotect the mouse model of Parkinson's disease.

Authors:  Xiao-Gang Gong; Hong-Mei Sun; Yi Zhang; Shu-Jing Zhang; Yu-Shan Gao; Jing Feng; Jing-Hong Hu; Cong Gai; Zhen-Yu Guo; Hong Xu; Ling Ma
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-24       Impact factor: 2.629

7.  Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.

Authors:  Ana I Rodriguez-Perez; Ana Borrajo; Carmen Diaz-Ruiz; Pablo Garrido-Gil; Jose L Labandeira-Garcia
Journal:  Oncotarget       Date:  2016-05-24

8.  Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.

Authors:  Rita Valenzuela; Maria A Costa-Besada; Javier Iglesias-Gonzalez; Emma Perez-Costas; Begoña Villar-Cheda; Pablo Garrido-Gil; Miguel Melendez-Ferro; Ramon Soto-Otero; Jose L Lanciego; Daniel Henrion; Rafael Franco; Jose L Labandeira-Garcia
Journal:  Cell Death Dis       Date:  2016-10-20       Impact factor: 8.469

9.  The Anti-Parkinsonism Effects of KATP Channel Blockade in the 6-Hydroxydopamine-Induced Animal Model: The Role of Oxidative Stress.

Authors:  Hossein Piri; Hashem Haghdoost-Yazdi; Negin Fraidouni; Tahereh Dargahi; Mohamadhosein Yaghoubidoust; Abbas Azadmehr
Journal:  Basic Clin Neurosci       Date:  2017 May-Jun

Review 10.  Brain renin-angiotensin system and dopaminergic cell vulnerability.

Authors:  Jose L Labandeira-García; Pablo Garrido-Gil; Jannette Rodriguez-Pallares; Rita Valenzuela; Ana Borrajo; Ana I Rodríguez-Perez
Journal:  Front Neuroanat       Date:  2014-07-08       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.